President Trump has threatened to levy tariffs of up to 200% on pharmaceutical imports. Lilly's margins could be negatively affected if the company absorbs the higher costs. The active ingredients of ...

Johnson & Johnson (NYSE:JNJ) is one of the Most Undervalued High Quality Stocks to Buy According to Hedge Funds. On July 10, ...

The pharmaceutical sector continues to stand out as a resilient and highly profitable corner of the market, even amid global ...

Japanese SMEs like Mitsuwa Electric, a specialized manufacturer, are cautiously optimistic about weathering potential US ...

President Donald Trump's proposed tariffs on pharmaceuticals could lead to higher prices, higher insurance premiums, and even drug shortages, experts say.

Tariffs and the uncertainty surrounding them emerged as the biggest policy issue coming out of the first six months of the new administration.

Conversations with the Trump administration on its “most favored nation” policy have been productive, the executive said ...

Novartis ( NYSE: NVS) CEO Vas Narasimhan said the company has built up its U.S. inventories to help mitigate the impact of ...

Pharma prepares for looming tariffs, as the US president signals a phased increase starting Aug. 1, but the official starting ...

Swiss drugmaker Novartis nudged up its full-year earnings forecast on Thursday, citing strong second-quarter sales of key ...

W hen Donald Trump’s tariffs are mentioned, you might recall his “Liberation Day” duties on uninhabited islands, his on-again ...

Johnson & Johnson expects a smaller hit from tariffs than it predicted earlier in the year, despite uncertainty over the prospects of new U.S. levies on pharmaceuticals. J&J now predicts tariffs will ...